Which act primarily regulates the advertising and labeling of prescription drugs?

The Federal Food, Drug, and Cosmetic Act (FDCA) is the primary law governing the advertising and labeling of prescription drugs in the United States. This act was originally enacted in 1938 and has been amended several times to adapt to changes in the pharmaceutical industry and ensure consumer protection.

One of the key provisions of the FDCA is that it requires all drugs, including prescription medications, to be labeled with accurate and truthful information to prevent misleading claims. This includes information about the drug's ingredients, uses, warnings, and potential side effects. The FDCA also establishes the framework for the regulation of advertising practices, ensuring that any promotional materials are not deceptive and provide clear information to healthcare providers and patients.

Moreover, the FDCA is enforced by the Food and Drug Administration (FDA), which has the authority to issue regulations regarding drug advertising and labeling standards. The FDA monitors compliance with these standards to protect public health.

Understanding this context clarifies that the other acts listed do not primarily focus on advertising and labeling. The Drug Approval Act, while related to the approval and regulation of new drugs, does not address marketing and labeling specifically. The Prescription Drug Marketing Act focuses on the distribution and marketing practices of prescription drugs rather than their labeling and advertising. The Controlled